TransDigm Group Investing Cash Flow increased by 83.1% to -$164.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.8%, from -$167.00M to -$164.00M. Over 3 years (FY 2022 to FY 2025), Investing Cash Flow shows relatively stable performance with a 2.5% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$37.00M | -$25.00M | -$29.00M | -$451.00M | -$48.00M | -$41.00M | -$35.00M | -$776.00M | -$48.00M | -$50.00M | -$121.00M | -$1.57B | -$702.00M | -$24.00M | -$167.00M | -$158.00M | -$246.00M | -$973.00M | -$164.00M |
| QoQ Change | — | +32.4% | -16.0% | <-999% | +89.4% | +14.6% | +14.6% | <-999% | +93.8% | -4.2% | -142.0% | <-999% | +55.2% | +96.6% | -595.8% | +5.4% | -55.7% | -295.5% | +83.1% |
| YoY Change | — | — | — | — | -29.7% | -64.0% | -20.7% | -72.1% | +0.0% | -22.0% | -245.7% | -102.1% | <-999% | +52.0% | -38.0% | +89.9% | +65.0% | <-999% | +1.8% |